ROYALTY PHARMA PLC- CL A
RPRXNASDAQ🏆 #457 by market capEarnings Nov 4US Equity
$59.00▲ $1.23 (+2.09%)
Live1h▲ 0.0%
24h▲ 2.1%
7d▲ 2.2%
14d▼ 0.3%
30d▲ 4.5%
1y▲ 64.6%
🏦Market Cap
$26.15B
Mid Cap
📈Revenue Growth (YoY)
+5.1%
Slowing
📊Gross Margin
89.4%
High
💵FCF Margin
117.4%
Strong
⚖️P/S Ratio
10.3x
Elevated
Otter Score
57
Weak
📊
Analyst Ratings
Price
$59.00
Total
11
Raised
0
Lowered
0
Avg PT
$59.50
H / L
$66 / $50
| Institution | Action | Rating | Date |
|---|---|---|---|
TD Cowen | Reiterated | Buy | 2026-07-13 |
JP Morgan | Reiterated | Overweight | 2026-05-07 |
Citigroup | Reiterated | Buy | 2026-05-07 |
UBS | Reiterated | Buy | 2026-04-21 |
Morgan Stanley | Reiterated | Overweight | 2026-04-10 |
Goldman Sachs | Reiterated | Buy | 2024-08-14 |
B of A Securities | Reiterated | Buy | 2024-04-12 |
Tigress Financial | Reiterated | Buy | 2023-04-06 |
Scotiabank | Reiterated | Outperform | 2022-09-13 |
Cowen & Co. | Reiterated | Outperform | 2020-07-13 |
SunTrust Robinson Humphrey | Reiterated | Buy | 2020-07-13 |
One row per institution, most recent rating